posted on 2018-03-08, 11:49authored byKaren L. Woolley, Elise Magatova, Yukiko Homma, Emma A. Platt, Paul Lane
<p><b>Objective:</b> Since
1998, JAMA has published peer-reviewed Patient Pages to help healthcare professionals
(HCPs) promote credible information to patients; with growing
patient-empowerment and access to social media, the public may now be the primary
promotors. We investigated engagement with JAMA’s Patient Pages via Twitter.</p>
<p><b>Research design and
methods:</b> For this controlled cross-sectional analysis, sequential (November
2013–November 2015; n=86) free-access
JAMA Patient Pages were matched for topic and time to JAMA articles
(controlling for journal; n=86) and to free‑access, MEDLINE®-listed
articles (controlling for access; n=86). Altmetric.com and Twitter data were analysed
by an independent academic statistician.</p>
<p><b>Results:</b> For
Patient Pages (34 vs 8; P<.001), JAMA articles (28 vs 9; P<.001), and
MEDLINE® articles (1 vs 0; P=.002), the median number of tweets was significantly
higher for the public vs HCPs. The median number of Tweeters, median number of
followers, median Attention Scores, and percent of articles having the US as
the top Tweeting country were significantly higher for Patient Pages (49;
226,719; 35; 93%) and JAMA articles (47; 214,773; 42; 88%) vs MEDLINE® articles
(1; 183; 1; 22%); for each outcome, the difference between Patient Pages or
JAMA articles vs MEDLINE® was P<.001; no significant differences were
detected between Patient Pages vs JAMA articles.</p>
<p><b>Conclusions:</b> The
public may be more powerful promoters of peer‑reviewed publications, whether patient-centric or not,
than HCPs. Tweeters from the US were the strongest promoters of JAMA’s patient‑centric, peer-reviewed
publications.</p>
Funding
All authors are employees of Envision Pharma Group.